Rating Change
Needham reiterated its Buy rating on Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) on August 18, 2026.
reiterateNASDAQ:IMDX
Needham Reiterates Buy Rating on Insight Molecular Diagnostics Inc. (IMDX)
Needham reiterated its Buy rating on Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) on August 18, 2026.
At publication ·
What changed
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) · reiterate
- Firm
- Needham
- Rating
- Buy to Buy
- Price at event
- $4.28
- Market capitalization
- $149.6M
At a glance
Key takeaways
- Needham reiterated its Buy rating on Insight Molecular Diagnostics Inc. (IMDX) on August 18, 2026, with the stock trading at $4.28 and a market capitalization of $149.6 million.
Market Context
Insight Molecular Diagnostics Inc. operates in the Healthcare sector. The stock currently trades at $4.28 with a market capitalization of $149.6M.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Insight Molecular Diagnostics Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Insight Molecular Diagnostics Inc.
Among the 4 most recent ratings: 4 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | Needham | Buy | N/A |
| Feb 17, 2026 | Lake Street | Buy | N/A |
| Nov 11, 2025 | Needham | Buy | N/A |
| Aug 18, 2025 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View IMDX Stock Page
Frequently Asked Questions
What does the Buy rating mean for IMDX?
A rating of Buy from Needham reflects the analyst's outlook on Insight Molecular Diagnostics Inc. (NASDAQ:IMDX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IMDX forecast page.